Patterns of Tissue NGS Alterations are Associated with ctDNA Shedding in Non Small Cell Lung Cancer Tumors Harboring EGFR Mutations

被引：0
|
作者：
Di Lello, A. [1 ]
Torri, V. [2 ]
Behera, V. [1 ]
Wu, S. [1 ]
Hines, J. B. [1 ]
Bestvina, C. M. [1 ]
Thawani, R. [1 ]
Dolezal, J. M. [1 ]
Chin, J. [1 ]
Pezeshk, A. [1 ]
Esposito, A. [1 ]
Sacco, M. [1 ]
Husain, A. N. [1 ]
Segal, J. [1 ]
Wang, P. [1 ]
Vokes, E. [1 ]
Garassino, M. C. [1 ]
Cameron, R. B. [1 ]
机构：
[1] Univ Chicago, Chicago, IL USA
[2] Mario Negri Inst Pharmacol Res IRCCS, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06D.13
引用
收藏
页码：S327 / S328
页数：2
相关论文
共 50 条
  • [21] Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    Targeted Oncology, 2024, 19 : 125 - 125
  • [22] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Le, Xiuning
    Nadler, Eric
    Costa, Daniel B.
    Heymach, John Victor
    TARGETED ONCOLOGY, 2023, 18 (06) : 807 - 817
  • [23] Outcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status
    Hashimoto, K.
    Okuma, Y.
    Hakozaki, T.
    Watanabe, K.
    Hosomi, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [24] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    Targeted Oncology, 2023, 18 : 807 - 817
  • [25] Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Igawa, S.
    Sato, Y.
    Kusuhara, S.
    Harada, S.
    Shirasawa, M.
    Kurahayashi, S.
    Okuma, Y.
    Sugimoto, A.
    Sugita, K.
    Nakahara, Y.
    Otani, S.
    Fukui, T.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Sasaki, J.
    Masuda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2126 - S2127
  • [26] Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Igawa, Satoshi
    Ryuge, Shiichiro
    Ichinoe, Masaaki
    Nakashima, Hiroyasu
    Otani, Sakiko
    Nakahara, Yoshiro
    Fukui, Tomoya
    Sasaki, Jiichiro
    Kubota, Masaru
    Katagiri, Masato
    Murakumo, Yoshiki
    Satoh, Yukitoshi
    Sato, Yuichi
    Masuda, Noriyuki
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (1-2) : 7 - 13
  • [27] The Predictive Values of Advanced Non-Small Cell Lung Cancer Patients Harboring Uncommon EGFR Mutations-The Mutation Patterns, Use of Different Generations of EGFR-TKIs, and Concurrent Genetic Alterations
    Tan, Jiarong
    Hu, Chengping
    Deng, Pengbo
    Wan, Rongjun
    Cao, Liming
    Li, Min
    Yang, Huaping
    Gu, Qihua
    An, Jian
    Jiang, Juan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations
    Chen, Chi-Han
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Hsu, Ping-Chih
    Wu, Chiao-En
    ANTICANCER RESEARCH, 2022, 42 (04) : 2145 - 2157
  • [29] Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
    Ichihara, Eiki
    Hotta, Katsuyuki
    Takigawa, Nagio
    Kudo, Kenichiro
    Kato, Yuka
    Hondaa, Yoshihiro
    Hayakawa, Hiromi
    Minami, Daisuke
    Sato, Akiko
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    LUNG CANCER, 2013, 81 (03) : 435 - 439
  • [30] CUSTOMIZING ERLOTINIB IN METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P) HARBORING EGFR MUTATIONS
    Sirera, R.
    Catot, S.
    Gonzalez-Larriba, J. L.
    Bover, I.
    Alonso, G.
    Valdivia, J.
    Ibeas, R.
    Lianes, P.
    Martinez del Prado, P.
    Rosell, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 90 - 90
12345